Skip to main content

Advertisement

SpringerLink
Log in

Update in Women’s Health for the General Internist

  • Reviews
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rybo G. Tranexamic Acid Therapy—effective treatment in heavy menstrual bleeding. Clinical update on safety. Therapeutic Advances. 1991;4:1–8.

    Google Scholar 

  2. Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol. 1991;164(3):879–83.

    PubMed  CAS  Google Scholar 

  3. Mosher WD, Jones J. Use of contraception in the United States: 1982–2008. Vital and Health Statistics. 2010;23(29).

  4. Foster D, Parvataneni R, de Bocanegra H, Lewis C, Bradsberry M, Darney P. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet Gynecol. 2006;108(5):1107–14.

    Article  PubMed  Google Scholar 

  5. Jones R, Kooistra K. Abortion in the United States: Incidence and Access to Services, 2005. Perspect Sex Repod Health. 2008;40(1):6–16.

    Article  Google Scholar 

  6. Harper K, Sperry S, Thompson J. Viewership of pro-eating disorder websites: association with body image and eating disturbances. Int J Eat Disord. 2008;41(1):92–5.

    Article  PubMed  Google Scholar 

  7. Costin C. Your Dieting Daughter: Is She Dying for Attention?: Routledge; New York, New York 1996.

  8. Lucci A, McCall L, Beitsch P, American College of Surgeons Oncology Group, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657–63.

    Article  PubMed  Google Scholar 

  9. Moore E, Greenberg R, Merrick S, Miller S, McLoud T, Shepart J. Significance of incidental detection on CT scans. Radiology. 1989;172:711–6.

    PubMed  CAS  Google Scholar 

  10. Witteman J, Kok F, van Saase J, Valkenburg H. Aortic calcification as a predictor of cardiovascular mortality. Lancet. 1986;2:1120–1122.

    Article  PubMed  CAS  Google Scholar 

  11. Rossouw J, Anderson G, Prentice R, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

    Article  PubMed  CAS  Google Scholar 

  12. Loprinzi C, Sloan J, Stearns V, et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol. 2009;271(17):2831–7.

    Article  Google Scholar 

  13. Bath P, Gray L. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ. 2005;330(7487):342.

    Article  PubMed  Google Scholar 

  14. Hemelaar M, van der Mooren M, Rad M, Kluft C, Kenemans P. Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. Fertil Steril. 2008;90(3):642–72.

    Article  PubMed  Google Scholar 

  15. Chlebowski R, Hendrix S, Langer R, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 2003;289(24):3243–53.

    Article  PubMed  CAS  Google Scholar 

  16. Chlebowski R, Kuller L, Prentice R, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. NEJM. 2009;360(6):573–87.

    Article  PubMed  CAS  Google Scholar 

  17. Jackson R, et al. Calcium plus vitamin D supplementation and the risk of fractures. NEJM. 2006;354(7):669–83.

    Article  PubMed  CAS  Google Scholar 

  18. Bolland M, Barber P, Doughty R, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008;336:262–6.

    Article  PubMed  CAS  Google Scholar 

  19. Grant A, Anderson F, Avenell A, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium or Vitamin D, RECORD). Lancet. 2005;365(9471):1621–8.

    Article  PubMed  CAS  Google Scholar 

  20. Trivedi D, Doll R, Khaw K. Effect of four monthly oral vitamin D supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326(7387):469–75.

    Article  PubMed  CAS  Google Scholar 

  21. Chapuy M, Arlot M, Delmas P, Meunier P. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ. 1994;308(6936):1081–2.

    Article  PubMed  CAS  Google Scholar 

  22. Chapuy M, Arlot M, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. NEJM. 1992;327(23):1637–42.

    Article  PubMed  CAS  Google Scholar 

  23. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ. 2005;330(7498):1003.

    Article  PubMed  CAS  Google Scholar 

  24. Heikinheimo R, Inkovaara J, Harju E, et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int. 1992;51(2):105–10.

    Article  PubMed  CAS  Google Scholar 

  25. Smith H, Anderson F, Raphael H, Maslin P, Crozier D, Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women: a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2007;46(12):1852–7.

    Article  CAS  Google Scholar 

  26. Larsen E, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004;19(3):370–8.

    Article  PubMed  CAS  Google Scholar 

  27. Dawson-Hughes B, Harris S, Krall E, Dallal G. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. NEJM. 1997;337(10):670–6.

    Article  PubMed  CAS  Google Scholar 

  28. Lyons R, Johansen A, Brophy S, et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int. 2007;18(6):811–8.

    Article  PubMed  CAS  Google Scholar 

  29. Prince R, Austin N, Devine A, Dick I, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med. 2007;168(1):103–8.

    Article  Google Scholar 

  30. Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf. 2009;32:775–85.

    Article  PubMed  CAS  Google Scholar 

  31. Kwek E, Goh S, Koh J, Png M, Howe T. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008;39:224–31.

    Article  PubMed  Google Scholar 

  32. Capeci C, Tejwani N. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009;91:2556–61.

    Article  PubMed  Google Scholar 

  33. Odvina C, Levy S, Rao S, Zerwekh J, Sudhaker Rao D. Unusual mid-shaft fractures during long term bisphosphonate therapy. Clin Endocrinol (Oxf). 2009 March 19;(Epub ahead of print).

  34. Somford M, Draijer F, Thomassen B, Chavassieux P, Boivin G, Papapoulos S. Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility. J Bone Miner Res. 2009;24:1736–40.

    Article  PubMed  Google Scholar 

  35. Armamento-Villareal R, Napoli N, Diemer K, et al. Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates. Calcif Tissue Int. 2009;85:37–44.

    Article  PubMed  CAS  Google Scholar 

  36. Cheung R, Leung K, Lee K, Chow T. Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate. Hong Kong Med J. 2007;13:485–9.

    PubMed  Google Scholar 

  37. Armamento-Villareal R, Napoli N, Panwar V, Novack D. Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis. NEJM. 2006;355:2048–50.

    Article  PubMed  CAS  Google Scholar 

  38. Goh S, Yang K, Koh J, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 207;89:349–53.

  39. Odvina C, Zerwekh J, Rao D, Maalouf N, Gottschalk F, Pak C. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90:1294–301.

    Article  PubMed  CAS  Google Scholar 

  40. Visekruna M, Wilson D, McKiernan F. Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. 2008;93:2948–52.

    Article  PubMed  CAS  Google Scholar 

  41. Neviaser A, Lane J, Lenart B, Edobor-Osula F, Lorich D. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008;22:346–50.

    Article  PubMed  Google Scholar 

  42. Lenart B, Lorich D, Lane J. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. NEJM. 2008;358:1304–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was presented at the 2011 Annual Meeting of the Society of General Internal Medicine in Phoenix, Arizona.

Conflict of Interest

None disclosed.

Author information

Authors and Affiliations

  1. UCSF Division of General Internal Medicine, UCSF Women’s Health Clinical Research Center, University of California, 1635 Divisadero Suite 600, San Francisco, CA, 94115, USA

    Judith M. E. Walsh MD, MPH

  2. Louis Stokes Cleveland Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH, USA

    Megan McNamara MD, MSc

  3. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Redonda G. Miller MD, MBA

  4. Center for Research on Health Care, Departments of Medicine, Epidemiology, Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, USA

    Eleanor Bimla Schwarz MD, MS

Authors
  1. Judith M. E. Walsh MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Megan McNamara MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Redonda G. Miller MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eleanor Bimla Schwarz MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Judith M. E. Walsh MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walsh, J.M.E., McNamara, M., Miller, R.G. et al. Update in Women’s Health for the General Internist. J GEN INTERN MED 27, 232–237 (2012). https://doi.org/10.1007/s11606-011-1877-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-011-1877-4

Keywords

Search

Navigation